The latest Investing Matters Podcast episode featuring financial educator and author Jared Dillian has been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksASLR.L Regulatory News (ASLR)

  • There is currently no data for ASLR

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Directorate Change

21 Jun 2021 07:00

RNS Number : 4689C
Asimilar Group PLC
21 June 2021
 

 

 

21 June 2021

 

 

ASIMILAR GROUP PLC ('ASIMILAR' OR 'THE COMPANY')

 

Board Appointment and Grant of Warrants

 

Asimilar Group plc (AIM: ASLR), the AIM quoted investment company focused on technology opportunities in the fields of big data, machine learning, telematics and the Internet of Things (IoT), is pleased to announce that Michael Preen has been appointed to the Board of Asimilar as a Non-Executive Director with immediate effect. Following his appointment, he has been awarded 250,000 warrants over ordinary shares in the Company with an exercise price of 60p per share.

 

The Company also announces that its wholly owned subsidiary, Intrinsic Capital (Jersey) Limited, has changed its name to Asimilar Investments Limited.

 

Michael Preen is a qualified solicitor with 25 years' experience in the provision of legal, corporate and governance advisory services. He qualified and spent 6 years in the market-leading investment funds team at Norton Rose (now Norton Rose Fulbright), a major international law firm, before becoming a vice-president in the corporate advisory division at Dresdner Kleinwort Wasserstein, a European investment bank.

 

Following two years in Australia as a senior associate specialising in real estate investment funds with Mallesons Stephen Jaques (now King & Wood Mallesons), a leading law firm in the region, he returned to the UK and joined Development Capital Management, a global real estate fund management group, where he held a number of senior management roles and was instrumental in establishing its FCA regulated securities division.

 

From 2009 to 2014 he held the position of Head of Corporate and Legal Affairs at Hydrodec Group plc, an AIM listed clean tech oil company, before establishing his own corporate and governance consultancy business where he provides advisory services to the boards of various public and private companies, focussing on small cap technology clients.

 

Michael David Preen (age 48) holds or has held in the past five years the following directorships and/or partnerships:

 

Current

Past

Eversholt Academy Trust

None

Logos Capital plc

Preen Consulting Limited

Michael Preen, his related parties and members of his close family have an interest in 164,399 Asimilar ordinary shares, representing 0.14% of Asimilar's issued share capital.

There is no further information to be disclosed in relation to Michael Preen's appointment pursuant to AIM Rule 17 or Schedule Two, paragraph (g) (i)-(viii) of the AIM Rules for Companies.

Grant of Director Warrants

The Company has issued warrants to subscribe for 250,000 new ordinary shares ("Warrants") to Michael Preen following his appointment to the Board as Non-Executive Director on 18 June 2021. This represents 0.21% of the current issued share capital in the Company. The Warrants are exercisable at any time after 6 months and up to three years from the date of appointment and are exercisable at a price of 60 pence per share, and may be exercised, subject to the provisions of the Company's share dealing code.

 

 

1

Details of the person discharging managerial responsibilities/person closely associated

a)

Name

Michael Preen

2

Reason for the notification

a)

Position/status

Non-executive Director

b)

Initial notification/Amendment

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Asimilar Group Plc

b)

LEI

213800AYJZ2B8QNY7H15

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

 

Identification code

Warrants to subscribe for Ordinary shares of 0.01 pence per share par value 

 

GB00BFX2VL54

b)

Nature of the transaction

Issue of Warrants

c)

Price(s) and volume(s)

Price(s)

Volume(s)

60.0p

250,000

 

 

 

d)

Aggregated information

-

Aggregated volume

-

Price

 

250,000 Warrants to subscribe for Ordinary shares of 0.01 pence per share par value

60.0 pence per Ordinary share

e)

Date of the transaction

18 June 2021

f)

Place of the transaction

Outside a trading venue

 

 

-Ends-

Contacts

Asimilar Group plc

John Taylor, Non-Executive Chairman

via Buchanan

Cairn Financial Advisers LLP

Sandy Jamieson / Liam Murray

Tel: +44 20 7213 0880

Peterhouse Capital Limited

Duncan Vasey / Lucy Williams

Tel: + 44 20 7220 9797

Buchanan Communications Limited

Richard Oldworth / Chris Lane

Tel: +44 (0) 20 7466 5000

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOADBGDLSGDDGBG
Date   Source Headline
30th Apr 20149:30 amRNSDirectorate Change
14th Apr 20147:00 amRNSBusiness Update
9th Apr 20149:00 amRNSReplacement announcement: Director resignation
9th Apr 20147:00 amRNSDirector Resignation
12th Mar 20147:00 amRNSNew Contract Wins valued at more than £0.5m
5th Mar 20147:00 amRNSNotice of AGM
21st Feb 20147:00 amRNSFinal Results
10th Feb 201411:00 amRNSTrading Update & Notice of Results
17th Dec 20137:00 amRNSChange of UK Head Office & Registered Office
28th Nov 201311:00 amRNSTrading Statement
16th Aug 20137:00 amRNSAppointment of Director and Grant of Share Options
26th Jun 20137:01 amRNSAppointment of Broker
26th Jun 20137:00 amRNSHalf Yearly Report
24th Jun 20137:00 amRNSNew contract wins
15th May 20138:41 amRNSResignation of NED & Appointment of Head of Ops
23rd Apr 201312:37 pmRNSResult of AGM
19th Apr 20137:00 amRNSChange of Adviser
18th Apr 20137:00 amRNSStmnt re Share Price Movement
28th Mar 20137:00 amRNSFinal Results for the Year Ended 30 September 2012
26th Mar 20139:47 amRNSPentagon Protection signs distribution agreement
18th Mar 20137:00 amRNSLoan Agreement
21st Feb 20137:00 amRNSNew Contract Win Valued at £1.9m
22nd Jan 20137:00 amRNSNew contract wins
8th Nov 20127:00 amRNSTrading Update and Result of General Meeting
8th Oct 20127:00 amRNSNew Contract Gains
18th Sep 20127:00 amRNSFurther Contract Gains
3rd Jul 20127:00 amRNSFurther Contract Gains
27th Jun 20127:00 amRNSIssue of Equity and Capitalisation of Loan
7th Jun 20129:17 amRNSInterim Results
30th Apr 20127:00 amRNSFurther Contract Gains
17th Apr 201212:24 pmRNSTotal Voting Rights
16th Apr 20124:33 pmRNSResult of AGM
16th Apr 20127:00 amRNSPENTAGON ANNOUNCES CONTRACT GAINS ACROSS THE GROUP
11th Apr 20124:10 pmRNSRestriction on New Share Authorities
3rd Apr 20123:10 pmRNSAdjournment of AGM
8th Mar 20129:30 amRNSNotice of AGM and Share Capital Reorganisation
7th Mar 201210:38 amRNSFinal Results
17th Nov 20117:00 amRNSTrading Update
8th Sep 20117:00 amRNSContract Gains
9th Aug 20117:00 amRNSContract Awards
28th Jul 20117:00 amRNSNew Contract Win
30th Jun 20119:01 amRNSHalf Yearly Report
24th May 201111:26 amRNSNew Contract Win
28th Apr 20114:52 pmRNSContract Award and Resignation of Director
15th Apr 20115:09 pmRNSResult of AGM
18th Mar 201110:00 amRNSDoc re. Report and Accounts / Related Pty Tran
18th Mar 20119:52 amRNSFinal Results
24th Nov 201012:36 pmRNSAppointment of Director
12th Nov 20104:30 pmRNSResult of GM
26th Oct 20107:00 amRNSAcquisition & Notice of GM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.